Drug treatment of diseases characterized by abnormal movements.
D002819:Chorea / Q000188:drug therapy; D003975:Diazepam / Q000627:therapeutic use; D000431:Ethanol / Q000627:therapeutic use; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D007980:Levodopa / Q000627:therapeutic use; D009069:Movement Disorders / Q000188:drug therapy*; D009207:Myoclonus / Q000188:drug therapy; D010640:Phenothiazines / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D013747:Tetrabenazine / Q000627:therapeutic use; D013981:Tic Disorders / Q000188:drug therapy; D014103:Torticollis / Q000188:drug therapy; D005879:Tourette Syndrome / Q000188:drug therapy; D014202:Tremor / Q000188:drug therapy
D010640:Phenothiazines; D000431:Ethanol; D007980:Levodopa; D012110:Reserpine; D011433:Propranolol; D006220:Haloperidol; D003975:Diazepam; D013747:Tetrabenazine